Subscribe To
U.s. fda panel backs pfizer's rsv vaccine for protecting infants
Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc's experimental respiratory syncytial v...
May 18, 2023, 5:04 pm
Fda advisers vote in favor of pfizer maternal rsv vaccine
Advisers to the U.S. Food and Drug Administration voted Thursday in favor of Pfizer's respiratory syncytial virus v...
May 18, 2023, 5:00 pm
Fda advisors recommend pfizer's rsv vaccine for infants but raise safety concerns
The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall....
May 18, 2023, 4:52 pm
People at high risk to mpox should get 2 doses of bavarian nordic vaccine, us cdc says
The U.S. Centers for Disease Control and Prevention is urging people at high risk of mpox to get two doses of Bavarian Nordic's Jynneos v...
May 18, 2023, 1:12 pm
Rsv vaccine: here's what to know as fda advisors consider approving pfizer's shot
FDA analysts have flagged concerns over the risk of preterm birth for the shot, which is given to pregnant people to protect infants from RSV in their...
May 18, 2023, 8:31 am
Us fda advisers to discuss pfizer's maternal rsv vaccine
Advisers to the U.S. Food and Drug Administration on Thursday will discuss Pfizer Inc's experimental respiratory syncytial virus (RSV) v...
May 18, 2023, 7:03 am
3 magnificent growth stocks to buy to help build a millionaire portfolio
Amazon is a leader in two high-growth industries and should benefit from that over time. Moderna aims to capture as much as half of the respiratory v<...
May 18, 2023, 5:30 am
Vaccine adjuvants market size and value to reach usd usd 3,933.7 million by 2032 | growing at cagr of 13.6%
As per the latest finding of Market.us, Increasing usage of recombinant and synthetic vaccines is proje...
May 17, 2023, 9:21 am
Vaxcyte: positive phase 2 results elevate confidence in vax-24's potential
Vaxcyte is emerging as a leader in vaccine innovation, leveraging high-fidelity v...
May 17, 2023, 8:20 am
Pfizer rsv vaccine for infants has 'generally favorable' safety data, fda staff say
The FDA is slated to make a decision on whether to approve Pfizer's shot in August, just before respiratory syncytial virus season in the fall....
May 16, 2023, 12:35 pm
What to expect from gsk in 2023
GSK's operating income margin in Q1 2023 was 29.35%, showing an increase in the previous quarter and the last year. V...
May 16, 2023, 1:29 am
Gsk: so, just how big is the rsv opportunity? up to $9bn, says one broker
Shore Capital has examined the prospects of GSK PLC (LSE:GSK, NYSE:GSK)'s newly approved respiratory syncytial virus (RSV) v...
May 15, 2023, 11:11 am
Vbi vaccines, inc. (vbiv) reports q1 loss, misses revenue estimates
VBI Vaccines, Inc. (VBIV) came out with a quarterly loss of $2.43 per share versus the Zacks Consensus ...
May 15, 2023, 10:41 am
Is novavax finally turning things around?
Vaccine developer Novavax Inc. NASDAQ: NVAX stock shot up 28% following its Q1 2023 earnings report. Th...
May 15, 2023, 8:59 am
Novavax's new ceo leads vaccine trial success, and big layoffs too
Novavax's John C. Jacobs detailed his plan to cut costs and manage cash flow....
May 13, 2023, 6:00 am
Hillevax reports first quarter 2023 financial results and highlights recent company progress
BOSTON, May 12, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerci...
May 12, 2023, 8:05 pm
Ncla clients vindicated as biden ends covid vaccine mandates that federal courts already enjoined
Washington, D.C., May 11, 2023 (GLOBE NEWSWIRE) — Today, the Biden-Harris Administration is officially ending the disgraceful Covid-19 v...
May 11, 2023, 3:38 pm
The fda just approved an rsv vaccine -- and it isn't from moderna or pfizer
The global RSV vaccine market isn't all that big, and healthcare giants are battling for market share. ...
May 11, 2023, 10:23 am
Is the worst over for novavax?
Novavax is cutting costs and restructuring to stay afloat as vaccine demand declines. As part of that e...
May 10, 2023, 1:30 pm
Biontech braces for weak q2 as covid vaccine demand subsides
BioNTech is facing a weak second quarter of 2023 as demand for Covid vaccines wane throughout the warme...
May 10, 2023, 1:01 pm
